SCHEMBL3715941

SCHEMBL3715941

COC(=O)C(N)CCc1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.47
CYP2C19 P33261 3/20 0.47
CYP3A4 P08684 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
NFKB1 P19838 1/20 0.47
LMNA P02545 2/20 0.46
PMP22 Q01453 1/20 0.46
NLRP3 Q96P20 1/20 0.46
GAA P10253 2/20 0.44
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
POLB P06746 3/20 0.44
ALDH1A1 P00352 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3715937 1.00 DPP4 (0.47) DPP4CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL22444977 0.87 DPP4 (0.45) DPP4CYP1A2LMNAALDH1A1TAAR1
SCHEMBL22445204 0.87 L3MBTL1 (0.45) ALDH1A1TAAR1
SCHEMBL28829108 0.87 LNPEP (0.53) KDM4E
SCHEMBL8249891 0.87 LNPEP (0.53) KDM4E
Bromide SCHEMBL15019524 0.85 LNPEP (0.52) KDM4ETAAR1
SCHEMBL31341203 0.85 TSHR (0.48) DPP4LMNAGAAPOLBKDM4E
Bromide SCHEMBL15019522 0.85 LNPEP (0.52) KDM4ETAAR1
SCHEMBL28741572 0.85 TSHR (0.48) DPP4LMNAGAAPOLBKDM4E
SCHEMBL2734777 0.85 SLC6A2 (0.52) CYP2C19CYP3A4CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113692401-A Process for producing aromatic amino acid derivative 中外制药株式会社 2021-11-23 CN disclosed
WO-2020189540-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE 中外製薬株式会社 2020-09-24 WO disclosed
US-20100311798-A1 2-AMINOOXAZOLINES AS TAAR1 LIGANDS HOFFMANN-LA ROCHE, INC. 2010-12-09 US disclosed
WO-2010139707-A1 2-AMINOOXAZOLINES AS TAAR1 LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311798-A1 2-AMINOOXAZOLINES AS TAAR1 LIGANDS TAAR1, TAAR5, NPY2R DPP4 2383/4885CYP2C19 443/4885CYP3A4 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.